Caris, one of the truly forward-thinking companies on this planet, presented a number of research abstracts at the ASCO cancer conference — many in collaboration with members of the Caris Precision Oncology Alliance, the leading cancer research enterprise made up of more than 90 cancer centers, academic institutions, research consortiums and healthcare systems.
Below, take a look at what the Caris executives themselves are telling us about some of their latest goals and accomplishments.
Meantime, for years I’ve kept my eye on the cancer vaccine universe, hoping to see some real movement. After all, I live almost within eyeshot of The Salk Institute, where the legendary Jonas Salk did his global work.
Hoping for a new barrage of cancer vaccines has gotten me nowhere. It has been a largely futile exercise. But things are changing. It is finally happening.
This may or may not be the result of the pandemic and Moderna’s work. But the merger of vaccines and cancer treatments have certainly moved the ball forward.
And then there is alcohol. Folks definitely don’t want to hear this, but alcohol causes thousands of cancer cases in the U.S. each year and many more around the globe.
A new report reveals that abstaining from drinking altogether cuts the risk of at least two cancers – oral cavity and esophagus cancers.
What’s New This Week:
Caris Life Sciences is Revolutionizing Cancer Care
Want to Reduce Your Cancer Risk? Stop Drinking – Or Cut Back
Innovative Vaccines at ASCO 2024: A Glimpse into the Future of Cancer Treatment
